Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

mepha pharma ag - calcipotriolum, betamethasonum - salve - calcipotriolum 50 µg, betamethasonum 0.5 mg ut betamethasoni dipropionas, paraffinum liquidum, polyoxypropyleni 15 aether stearylicus, vaselinum album, e 321 50 µg, ad unguentum pro 1 g. - la psoriasi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

almirall ag - calcipotriolum, betamethasonum - crema - calcipotriolum 0.05 mg, betamethasonum 0.5 mg ut betamethasoni dipropionas, isopropylis myristas, paraffinum liquidum, triglycerida media, alcohol isopropylicus, macrogoli 4 aether laurilicus, poloxamerum 407, macrogolglyceroli hydroxystearas 3.37 mg, carbomerum interpolymerum a, e 320 1 mg, trolaminum, dinatrii phosphas heptahydricus, natrii dihydrogenophosphas monohydricus, e 307, aqua purificata q.s. ad unguentum pro 1 g. - la psoriasi - synthetika

Unione Europea - italiano - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - farmaci per il trattamento delle malattie ossee - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - cholecalciferolum - soluzione orale - cholecalciferolum 4000 u.i., triglycerida media ad solutionem pro 1 ml. - vitamina d-preparato - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

streuli pharma ag - cholecalciferolum - soluzione orale - cholecalciferolum 4000 u.i., triglycerida media ad solutionem pro 1 ml. - vitamina d-preparato - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

drossapharm ag - cholecalciferolum - soluzione orale - cholecalciferolum 4000 u.i., triglycerida media ad solutionem pro 1 ml. - vitamina d-preparato - synthetika